An international comparative analysis of public reimbursement of orphan drugs in Canadian provinces compared to European countries
Abstract Background The Canadian government has committed to developing a national strategy for drugs for rare diseases starting in 2022. Considering this announcement, we conducted a comparative analysis to examine patient access to therapies for rare disease in Canada relative to Europe and the U....
Main Authors: | , , , , |
---|---|
Format: | Article in Journal/Newspaper |
Language: | unknown |
Published: |
figshare
2022
|
Subjects: | |
Online Access: | https://dx.doi.org/10.6084/m9.figshare.c.5877425 https://springernature.figshare.com/collections/An_international_comparative_analysis_of_public_reimbursement_of_orphan_drugs_in_Canadian_provinces_compared_to_European_countries/5877425 |